Technical review reveals critical processing determinants for 3D-printed biomedical photopolymers, highlighting the gap between resin formulation and final device compliance.
This white paper covers biomedical photopolymer materials for professional manufacturing workflows, including research, prototyping and development contexts where biological-contact considerations are relevant. Biomedical material selection requires distinction between resin-level formulation attributes and final device regulatory compliance. Legal manufacturer validation, device design, cleaning, post-cure, residual species profile, extraction behaviour and service-condition stability remain decisive.
No takes yet. Share an insight, caveat, or question.
Juan Segurola (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: